New onset refractory status epilepticus (NORSE)
Brief description of study
This is a multi-site study aiming at creating a biorepository of a rare disease, new onset refractory status epilepticus (NORSE), to establish clinical characteristics, outcomes and biomarkers of disease.
Clinical Study Identifier: s18-01938
Principal Investigator:
Claude Steriade.
Other Investigator:
Amy C. Jongeling.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.